Your browser doesn't support javascript.
loading
Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma.
van de Donk, Niels W C J; Moreau, Philippe; Plesner, Torben; Palumbo, Antonio; Gay, Francesca; Laubach, Jacob P; Malavasi, Fabio; Avet-Loiseau, Hervé; Mateos, Maria-Victoria; Sonneveld, Pieter; Lokhorst, Henk M; Richardson, Paul G.
Afiliação
  • van de Donk NW; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands;
  • Moreau P; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France;
  • Plesner T; Vejle Hospital and University of Southern Denmark, Vejle, Denmark;
  • Palumbo A; Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy;
  • Gay F; Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy;
  • Laubach JP; Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
  • Malavasi F; Laboratory of Immunogenetics, Department of Medical Sciences, University of Torino, Torino, Italy;
  • Avet-Loiseau H; Insitut Claudius Regaud, L'Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France;
  • Mateos MV; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Instituto de Biologia Molecular y Celular del Cancer, Universidad de Salamanca-Consejo Superior de Investigaciones Cientificas, Salamanca, Spain; and.
  • Sonneveld P; Department of Hematology, Erasmus MC Cancer Insitute, Rotterdam, The Netherlands.
  • Lokhorst HM; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands;
  • Richardson PG; Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
Blood ; 127(6): 681-95, 2016 Feb 11.
Article em En | MEDLINE | ID: mdl-26631114
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores Imunológicos / ADP-Ribosil Ciclase 1 / Anticorpos Monoclonais / Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores Imunológicos / ADP-Ribosil Ciclase 1 / Anticorpos Monoclonais / Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2016 Tipo de documento: Article